A Comparative Study Of Figo 1988 Versus 2009 Staging For Endometrial Carcinoma

Objectives: The aim of this study was to investigate the benefits of the newly revised "The international federation of gynecology and obstetrics (FIGO), 2009" sytem and whether there was a difference in new system comparison to 1988 FIGO staging sytem for endometrial carcinoma.Methods: A total of 132 patients who underwent complete surgical staging for endometrial cancer were enrolled retrospectively. Those patients' overall survival and disease free survival were compared with 1988 and 2009 staging system.Results: The five year overall survival (OS) rates for patients with 1988 FIGO stage 1 and 2 were 97% and 100%, respectively. In 2009 system, the OS rates for 1 and 2 were 97% and 100%, respectively. There was no statistically significant differences between stage 1 and stage 2 for OS rates in 1988 and 2009 as well.Conclusions: The newly revised system could be less complex for understanding, but it does not discriminate survival rates better, especially in earlier stages. A new staging system and uniform surgical staging could be discussed.